SEMVICITY
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

SEMVICITY Trademark

Serial Number: 90321961

SEMVICITY is a trademark filed by Jazz Pharmaceuticals Research UK Limited on November 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

Trademark Details

Filing Date

November 16, 2020

Registration Date

Not Registered

Published for Opposition

December 21, 2021

Goods & Services

Pharmaceutical and veterinary preparations and substances for the treatment of neurological conditions, disorders, and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, chron's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; Pharmaceutical preparations and substances for the treatment of neurological conditions, disorders, and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; Medicinal infusions for treating neurological conditions, disorders, and diseases; Pure extracts of medicinal plants and herbs for medical purposes; Dietetic foods adapted for medical purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 9, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 9, 2025 ABN6
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 24, 2025 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2024 EXRA
SOU EXTENSION 5 GRANTED
Aug 1, 2024 EX5G
SOU EXTENSION 5 FILED
Aug 1, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 1, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 18, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 18, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 13, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 13, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 15, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 15, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 10, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 8, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 8, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 8, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 14, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 14, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 14, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 14, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 3, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 3, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 26, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 19, 2020 NWAP